Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (12908)	12/31/1997 10:01:00 PM
From: Henry Niman	Read Replies (3) \| Respond to of 32384

TD, I suspect that the reporter involve a little "poetic license" on the shot of the Ligand vial. Ligand has in-licensed Aldesleukin from CHIR and PHOTOFRIN from QLTIF and both are sold in Canada. Aldesleukin (IL-2) I would think is a liquid and I think that Photofrin is also. Thus, such a vial with a Ligand label might have been used to show who made the retinoid. All 3 of LGND's retinoids are in clinical trials but not being sold (so I'm not sure how fancy the label is). None of the retinoids are liquids, they are capsules (which are appropriate for head & neck tumors) or gels (for topical treatment of KS by Panretin or CTCL by Targretin).